Skip to main content

MILLENNIUM MANAGEMENT LLC

Position in ENGN — enGene Therapeutics Inc.

CIK 1273087 NEW YORK, NY

Position in ENGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,672,264
-$4,863,163 QoQ
Shares Held
966,627
+0.7% QoQ
Ownership
1.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 60 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENGN Over Time

Shares Held

Position Value (USD)

Derivatives in ENGN

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
69,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. ENGN ranks #221 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENGN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 ENGNW 69,000
2026-06-30 $1,672,264 966,627
2026-03-31 $6,535,427 959,681
2025-12-31 $13,540,665 1,499,520
2025-09-30 $140,028 20,502
2025-06-30 $47,429 13,030